Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CXSB1200002	注射用重组变构人肿瘤坏死因子相关凋亡诱导配体	Aponermin	Lyophilized	Biological Products	Supplementary Application	2012-04-24	北京沙东生物技术有限公司	Beijing Shadong Biotech Co Ltd	Certificate Issued	2012-12-25	view
CXSB1200001	注射用重组变构人肿瘤坏死因子相关凋亡诱导配体	Aponermin	Lyophilized	Biological Products	Supplementary Application	2012-04-24	北京沙东生物技术有限公司	Beijing Shadong Biotech Co Ltd	Certificate Issued	2012-12-25	view
CXSB1200003	注射用重组变构人肿瘤坏死因子相关凋亡诱导配体	Aponermin	Lyophilized	Biological Products	Supplementary Application	2012-04-24	北京沙东生物技术有限公司	Beijing Shadong Biotech Co Ltd	Certificate Issued	2012-12-25	view
CXSB1200004	注射用重组变构人肿瘤坏死因子相关凋亡诱导配体	Aponermin	Lyophilized	Biological Products	Supplementary Application	2012-04-24	北京沙东生物技术有限公司	Beijing Shadong Biotech Co Ltd	Certificate Issued	2012-12-25	view
CXSS2101065	注射用重组变构人肿瘤坏死因子相关凋亡诱导配体	Aponermin	Lyophilized	Biological Products(1)	New Drug Application	2021-12-20		Wuhan Hiteck Biological Pharma Co Ltd			view